Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
New hope for Alzheimer's sufferers as breakthrough allows scientists to grow new brain cells from normal skin
A single genetic tweak is all that is needed to turn ordinary skin cells into functioning brain cells, scientists have shown.
Gladstone cardiovascular and stem cell research director Dr. Deepak Srivastava weighs in on new research breakthrough finding from UC Berkeley.
For the first time scientists have managed to turn skin cells into fully functional brain cells.
New breakthroughs in cell engineering might usher in a new era of personalized medicine where drugs can be tested for side effects without having to test the drug in humans.
Scientists who reprogrammed skin cells into brain cells say their research could lay the groundwork for new ways to treat Alzheimer's and other brain diseases.
Gladstone Cardiovascular Disease Research Director Dr. Deepak Srivastava is quoted in this report of a breakthrough finding from UC Berkeley.
When San Francisco-based Salesforce said in 2010 it was moving into Mission Bay, many in the life sciences community were disappointed that the medical and biotech enclave would be filled by high tech workers.
Bruce Spaulding, one of the architects of San Francisco’s Mission Bay biotech enclave, is retiring for health reasons from the foundation supporting the Gladstone Institutes.
Deepak Srivastava, a cardiovascular researcher at the Gladstone Institute in San Francisco, was awarded a $6.3 million grant from the agency today, one of about twenty investigators to receive funds for translational programs.
A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuronsuggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer’s disease.